Fibroid tumors

Also found in: Dictionary, Thesaurus, Encyclopedia.

Fibroid tumors

Fibroid tumors are non-cancerous (benign) growths in the uterus. They occur in 30-40% of women over age 40, and do not need to be removed unless they are causing symptoms that interfere with a woman's normal activities.

Mentioned in: Abortion, Therapeutic, Postmenopausal Bleeding

Patient discussion about Fibroid tumors

Q. uterine fibroids. Whats the best way to deal with them? My doctor says hysterectomy? What about my hormones?

A. Yes, drugs that suppress the levels of the female sex hormones (estrogen) are successful for treating uterine fibroids. However, the relief is only temporary and the fibroids recur once the treatment is stopped. In addition, these treatments cause side effects similar to menopause.

Surgery is the definitive treatment, especially for complications such as bleeding or pain, and when there's a suspicion for malignancy.

You may read more here: http://www.nlm.nih.gov/medlineplus/ency/article/000914.htm

More discussions about Fibroid tumors

References in periodicals archive ?

The variation in relative amounts of IGF-I mRNA reported in these studies may have been due to the heterogeneity that exists among fibroid tumors (Rein and Nowak 1992).

Etiology and pathogenesis of uterine leiomyomas: a review. (Research Review)

The new technology uses highly focused ultrasound to ablate, or break down, fibroid tumors.

New Nonsurgical Option for Women Suffering from Painful Fibroid Tumors

Uterine fibroid embolization (UFE) is a minimally invasive interventional radiology treatment that blocks the blood supply to the fibroid tumors, causing them to shrink and die, alleviating symptoms.

Long-Term Data Show Uterine Fibroid Embolization Is Effective Treatment for Uterine Fibroids; Five-Year Follow Up Shows Interventional Radiology Procedure is Durable

She pioneered the use of women's self-care treatments based on diet, nutrition, exercise and stress management, and has penned a number of books, including Fibroid Tumors & Endometriosis and the Estrogen Decision.

Phillips Health and Susan Lark, MD Create New Formula to Fight Fatigue and Enhance Mental and Physical Performance

The first tranche has already been completed, and the second tranche is conditioned on the approval of the US Food and Drug Administration of InSightec's focused ultrasound technology for the treatment of uterine fibroid tumors.

Elbit Medical Imaging Subsidiary InSightec Announces $21 Million Investment

This was a Phase I study of 30 patients with symptomatic fibroid tumors.

BioSphere Medical Announces Publication of Favorable Phase I Clinical Trial Results Of Embosphere-R- Microspheres

WASHINGTON, April 19 /PRNewswire/ -- Lycopene, the antioxidant found in tomatoes that gives them their red color, may be able to reduce the size and incidence of fibroid tumors based on an animal study presented today at the annual Experimental Biology meeting being held here this week.

Lycopene Linked to Reduction in Fibroid Tumors; Study Presented at Experimental Biology Meeting Shows Promise for Women

NASDAQ: BMED), can help reduce the number of hysterectomies in women suffering from benign uterine fibroid tumors and provide less invasive, less costly alternatives for women requiring other types of gynecological surgery.

Valley Forge Announces Release of Gynecological Surgical Products

PHOENIX, March 26 /PRNewswire/ -- The first large, multi-center, comparative trial shows that uterine fibroid embolization -- a minimally invasive interventional radiology treatment that blocks the blood supply to the fibroid tumors, causing them to shrink -- offers a much quicker recovery and a lower adverse event rate compared to myomectomy, the surgical removal of uterine fibroids.

Study Shows Minimally Invasive Uterine Fibroid Embolization Treatment Offers Much Quicker Recovery, Shorter Hospital Stays, and is Safer With Lower Adverse Event Rates than Myomectomy Surgery

These include excessive menstrual bleeding, cancer, nonmalignant fibroid tumors and endometriosis, an inflammation of the lining of the uterus.

CooperSurgical completes acquisition of Unimar; plans leadership role in women's healthcare by consolidating fragmented market

The FDA's approval of mifepristone also clears a path for long-stalled trials of mifepristone's other possible beneficial applications in treating uterine fibroid tumors, ovarian cancer, endometriosis, and meningioma (brain tumors).

American Medical Women's Association Comments on FDA Approval Of Mifepristone (RU-486)

The study is being conducted at two clinical sites in Europe, and will include up to 50 patients undergoing surgery for removal of uterine fibroid tumors (myomectomy).

Confluent Surgical, Inc. Begins SprayGel(TM) Adhesion Barrier System Clinical Trial